TrialScientific reports2022

Effects of rifampin on the pharmacokinetics and pharmacodynamics of milvexian, a potent, selective, oral small molecule factor XIa inhibitor.

Vidya Perera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.